Spyre Therapeutics, Inc.
NASDAQ:SYREBiotechnology
Healthcare
$97.63 +1.38%
+$1.21 today
- Market cap
- $9.27B
- Beta
- 3.06
- P/E (TTM)
- -171.1
- EPS (TTM)
- -$0.52
52W Low $14.00High $91.04
Volume 0.63M
Average 1.17M
Private 5-step workspace
Build a SYRE investment thesis
Turn Spyre Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.